Electrochemical iodination of n,n'-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide

US2024271295A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024271295-A1
Application numberUS-202218694306-A
CountryUS
Kind codeA1
Filing dateSep 22, 2022
Priority dateSep 24, 2021
Publication dateAug 15, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention is related to a process for preparing a iodinating X-rays contrast agent. More specifically, it relates to a process for the preparation of N,N′-bis-(2,3-dihydroxypropyl)-5-hydroxy-2,4,6-triiodo-1,3-benzenedicarboxaniide (I) by electrochemical iodination of N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) with molecular iodine (I2) which is in situ electrochemically generated from a source of iodide ions (I−). The iodide ions (I−) are obtained by the dissolution of hydrogen iodide (HI) or an alkali metal iodide in the reaction medium or produced during the reaction of N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide with I2. The invention also relates to the use of the intermediate compound of formula (I), obtained through the above electrochemical iodination of compound (II), in the preparation of N,N′-bis[2,3-dihydroxypropyl]-5(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide (iomeprol).

First claim

Opening claim text (preview).

1 . A process for the preparation of N,N′-bis-(2,3-dihydroxypropyl)-5-hydroxy-2,4,6-triiodo-1,3-benzenedicarboxamide (I), comprising the steps of a) dissolving N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) in a reaction medium in the presence of molecular iodine (I 2 ) and b) iodinating said compound (II) with molecular iodine (I 2 ) to obtain said compound (I), wherein the reaction medium is an aqueous solution and molecular iodine (I 2 ) is in situ electrochemically generated from a source of iodide ions (I − ). 2 . The process according to claim 1 wherein the aqueous solution is water. 3 . The process according to claim 1 wherein steps a) and b) are carried out in galvanostatic mode using an undivided electrolytic cell. 4 . The process according to claim 1 , wherein molecular iodine (I 2 ) is electrochemically generated from a source of iodide ions (I − ) selected from HI and an alkali metal iodide by applying a constant electric current. 5 . The process according to claim 1 , wherein molecular iodine (I 2 ) is electrochemically re-generated from iodide ions (I − ) produced by the reaction of N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) with I 2 by applying a constant electric current which is switched on after a time ranging from 1 hour to 6 hours. 6 . The process according to claim 4 , wherein the applied electric current is comprised in the range from 5 to 100 mA/cm 2 . 7 . The process according to claim 3 , wherein the reaction medium is kept at pH comprised in the range from 5 to 7.5 by addition of a protic acid and at a temperature comprised between 40° C. and 60° C. 8 . The process according to claim 1 , wherein steps a) and b) are carried out in potentiostatic mode using an electrolytic cell formed by two-compartments divided by a porous septum or by a ionic exchange membrane. 9 . The process according to claim 8 , wherein molecular iodine (I 2 ) is electrochemically re-generated from iodide ions (I − ) produced by the reaction of N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) with I 2 by applying a constant voltage producing an anode potential from 0.5 to 0.9 V vs SCE (saturated calomel electrode). 10 . The process according to claim 8 , wherein the reaction medium is kept at pH from 10 to 12 by addition of a strong base and at a temperature comprised between 50° C. and 70° C. 11 . The process according to claim 8 wherein the two compartments of the cell are separated by a cationic membrane. 12 . The process according to claim 8 , wherein the electrolytic cell comprises an anodic compartment filled with an aqueous solution of compound (II) and I 2 according to step a) of claim 1 (anolyte) and a cathodic compartment filled with a 0.1-0.5 M NaOH solution (catholyte). 13 . The process according to claim 12 which is carried out in flux conditions by recirculating the anolyte and catholyte solutions. 14 . The process according to claim 1 further comprising the following step: c) isolating the compound of formula (I) obtained through the electrochemical iodination of compound (II). 15 . A process for preparing N,N′-bis[2,3-dihydroxypropyl]-5(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide (IV) comprising the steps of: a) dissolving N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) in a reaction medium in the presence of molecular iodine (I 2 ); b) iodinating said compound (II) with molecular iodine (I 2 ) to obtain N,N′-bis-(2,3-dihydroxypropyl)-5-hydroxy-2,4,6-triiodo-1,3-benzenedicarboxamide (I); c) isolating said compound (I); d) reacting said compound (I) with ClCH 2 (CO)NHCH 3 to obtain the intermediate (III) e) subjecting said intermediate (III) to Smile's rearrangement in the presence of a base, so as to obtain the final compound N,N-bis[2,3-dihydroxypropyl]-5(hydroxyacetyl)methylamino]-2,4,6-triiodo-1,3-benzenedicarboxamide (IV) wherein the reaction medium of step a) is an aqueous solution, and the molecular iodine (I 2 ) in step b) is in situ electrochemically generated from a source of iodide ions (I − ). 16 . The process according to claim 4 , wherein the alkali metal iodide is NaI or KI. 17 . The process according to claim 8 , wherein molecular iodine (I 2 ) is electrochemically re-generated from iodide ions (I − ) produced by the reaction of N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) with I 2 by applying a constant voltage producing an anode potential from 0.65 to 0.7 V vs SCE (saturated calomel electrode).

Assignees

Inventors

Classifications

  • having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring · CPC title

  • by reactions not involving the formation of carboxamide groups · CPC title

  • Halogen containing compounds · CPC title

  • Nitrogen containing compounds · CPC title

  • Recycling of electrolyte to electrochemical cell · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024271295A1 cover?
The invention is related to a process for preparing a iodinating X-rays contrast agent. More specifically, it relates to a process for the preparation of N,N′-bis-(2,3-dihydroxypropyl)-5-hydroxy-2,4,6-triiodo-1,3-benzenedicarboxaniide (I) by electrochemical iodination of N,N′-(2,3-dihydroxypropyl)-5-hydroxy-1,3-benzenedicarboxamide (II) with molecular iodine (I2) which is in situ electrochemica…
Who is the assignee on this patent?
Bracco Imaging Spa
What technology area does this patent fall under?
Primary CPC classification C25B3/27. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Aug 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).